Literature DB >> 7482734

Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor.

P G Beatty1, M Mori, E Milford.   

Abstract

As successful organ or marrow transplantation correlates with the degree of HLA-compatibility between patient and donor, registries have been developed to facilitate matching. However, racial minority groups have a lower chance of finding a match. We evaluate the impact of the biology of racial genetic polymorphism upon the probability of finding an HLA match for patients of different racial groups. The National Marrow Donor Program has compiled the HLA types of 20,449 patients and 1,625,159 potential volunteer donors. These HLA types were used to estimate the probability of finding an HLA-matched donor for patients of different racial groups. We estimated the HLA haplotype frequencies for different races, and then determined the probability of finding matched donors, given several hypothetical registry sizes. We confirmed that patients of minority races searching the current National Marrow Donor Program registry have low probabilities of finding matches. This was only partly due to the smaller number of donors from these racial minorities, as the observation persisted even when hypothetical donor registry sizes were the same for all racial groups. We demonstrate that African-Americans are more polymorphic with respect to HLA, and are hence less likely to find donors at any given registry size. An increase in the recruitment of minority racial groups for organ and marrow donors will only partially alleviate the problem of equal access to HLA matches for patients belonging to racial minority groups. It will therefore be important to attempt to improve methods for transplantation using HLA-mismatched donors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482734

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  36 in total

Review 1.  Overview of T-cell depletion in haploidentical stem cell transplantation.

Authors:  Nicola Daniele; Maria Cristina Scerpa; Maurizio Caniglia; Chiara Ciammetti; Cecilia Rossi; Maria Ester Bernardo; Franco Locatelli; Giancarlo Isacchi; Francesco Zinno
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

2.  The role of minority geographic distribution in waiting time for deceased donor kidney transplantation.

Authors:  G M Vranic; J Z Ma; D S Keith
Journal:  Am J Transplant       Date:  2014-08-25       Impact factor: 8.086

Review 3.  Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors.

Authors:  H J Symons; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-08-04       Impact factor: 5.483

4.  The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.

Authors:  N Or-Geva; Y Reisner
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 5.  Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignancies.

Authors:  Michael J Ricci; Jeffrey A Medin; Ronan S Foley
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

6.  Estimation of size of cord blood inventory based on high-resolution typing of HLAs.

Authors:  E Y Song; J Y Huh; S Y Kim; T G Kim; S Oh; J H Yoon; E Y Roh; M H Park; M S Kang; S Shin
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

Review 7.  Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies.

Authors:  Mary Eapen; Paul O'Donnell; Claudio G Brunstein; Juan Wu; Kate Barowski; Adam Mendizabal; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-23       Impact factor: 5.742

8.  Race and ethnicity in decisions about unrelated hematopoietic stem cell donation.

Authors:  Galen E Switzer; Jessica G Bruce; Larissa Myaskovsky; Andrea DiMartini; Diana Shellmer; Dennis L Confer; Linda K Abress; Roberta J King; Allyson G Harnaha; Sibylle Ohngemach; Mary Amanda Dew
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

9.  Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.

Authors:  Johnnie J Orozco; Aimee Kenoyer; Ethan R Balkin; Ted A Gooley; Donald K Hamlin; D Scott Wilbur; Mark D Hylarides; Sofia H L Frost; Raya Mawad; Paul O'Donnell; Brenda M Sandmaier; Ephraim J Fuchs; Leo Luznik; Damian J Green; Ajay K Gopal; Oliver W Press; John M Pagel
Journal:  Blood       Date:  2015-11-17       Impact factor: 22.113

Review 10.  Non-medical factors influencing access to renal transplantation.

Authors:  Eszter Panna Vamos; Marta Novak; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-04-07       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.